![mAb ADC Protein Drugs](https://www.avancebio.com/wp-content/uploads/mAb-ADC-Protein-Drugs-scaled.jpg)
Analytical Services for mAb, ADC, and Protein Drugs
Our Expertise
We are dedicated to accelerating your biologic drug development process and ensuring the safety, efficacy, and quality of your therapeutic candidates. Our expertise spans genomics, proteomics, microbial analysis, and immunoassays, supporting a wide range of biologics, including monoclonal antibodies (mAbs), Antibody-drug conjugates, protein drugs, and other therapeutic proteins. Explore our detailed service offerings below, categorized into preclinical studies, clinical studies, and Chemistry, Manufacturing, and Controls (CMC)
Analytical Support Through All Stages of Product Lifecycle
Phase
Technologies
Applications
Development
qPCR, ddPCR, Sanger Sequencing, NGS, Flow Cytometry, ELISA, MSD, LC/MS/MS, Western Blot, Cell-Based Assays
-
Cell line development support
- Clone selection/screening
- Genetic stability testing
- Growth kinetics analysis
- mAb /Protein Expression and Characterization
Preclinical Studies
qPCR, ddPCR, Flow Cytometry, ELISA, MSD, LC/MS/MS
-
Preclinical PK/PD studies
- Immunogenicity studies
- Biomarker analysis
- In vitro efficacy studies
- Cytokine release assays
Clinical Studies
qPCR, ddPCR, Sanger, NGS, Flow Cytometry, ELISA, MSD, LC/MS/MS
- Clinical PK/PD studies
- patient stratification
- Immunogenicity testing
- Biomarker validation
- Companion diagnostics development
- Cytokine release assays
CMC Support
qPCR, ddPCR, Sanger, NGS, Flow Cytometry, ELISA, MSD, LC/MS
-
Identity assays
- Stability Testing
- Potency Assays
- Batch consistency
- Product characterization
- Impurity profiling
- Compendial assays